Abstract Submission

Click on the links below to go directly to any of the following sections:
o    How to Write an Abstract
o    Submit your Abstract(s)
o    Abstract Submission Guidelines
o    Platform Presentation Information
o    Poster Display Details 
o    Poster and Platform Presentation Awards
o    Questions 

How to Write an Abstract

Are you ready to submit your abstract? The ISOPP Research Committee has prepared a resource on how to write an abstract for a scientific meeting.  A useful tool guiding you in the process of preparing a well-written abstract, especially if it is your first time.  Review the guide for some ‘tips an tricks’.


Submit your Abstract(s)

Abstract submission closed on Monday, May 6, 2019.


Acceptance Notification

The submitting author will be notified of acceptance by email the week of June 11, 2019.

                                                                                                                                                                                                         Back to top


Abstract Submission Guidelines

Acceptance Submission and Review Timeline

The deadline for abstract submission is Monday, May 6, 2019, midnight UTC. Peer review by the Abstract Review Task Force will take place between Wednesday, May 8 and Monday, May 29. The submitting author will be notified of acceptance by email the week of June 11, 2019.


Presenting Author Registration

The presenting author MUST register for ISOPP 2019 by Monday, July 15, 2019 or the abstract will automatically be withdrawn.


Publication of Abstracts

All accepted abstracts will be published in an issue of the Journal of Oncology Pharmacy Practice provided the presenting author registers for the Symposium by Monday, July 15, 2019. By submitting an abstract, you consent to the publication of this abstract.


Conflict of Interest Disclosure

During the abstract submission process, you will be asked to disclose any conflict of interest.


Author Information

The first author MUST be the presenting author.

Information required from all authors:

  • Name
  • Phone number
  • Email address
  • Affiliation
  • ISOPP member or non-member

                                                                                                                                                                                                       Back to top

Preferred Presentation Type

Please select one of the following presentation options during online abstract submission:

  1. Platform or Poster (only ISOPP and BOPA members will be considered for platform (oral) presentations)
  2. Poster

Encore presentations are only accepted as posters.


Abstract Categories
  1. Process Improvement/Pharmacoeconomics (PR): includes drug preparation and delivery, projects to enhance patient care or improve effectiveness or efficiency of pharmacy services; cost-benefit analyses; cost-effectiveness analyses
  2. Clinical Science (CS): includes oncology/pharmacy practice; MUEs; innovative patient care services/activities; unusual/unique clinical and/or management cases; projects to document pharmacy interventions
  3. Translational/Basic Science (TS): pharmacokinetics, pharmacodynamics, pharmacogenomics
  4. Trainee (TR): Student/Resident Fellow/Pharmacy intern/pharmacist-in-training, etc.
  5. Encore Presentation (EN): For data/abstract that has previously been presented at another meeting or published in profession journal


Abstract Title
The abstract title must be less than 150 characters. If the title is longer than 150 characters, you will not be able to submit your abstract. Please use title case e.g. Upper and Lower Case and NOT UPPER CASE.
Abstract Length

The abstract length is limited to 500 words not including the abstract title, author names or affiliations.


Abstract Content

The submission system will prompt you to follow the following abstract format:

  1. Objective/Purpose
  2. Study Design/Methods
  3. Results/Key Findings
  4. Conclusion/Recommendations

Abstracts must describe completed research (abstracts that contain results and conclusions).


Abstracts are accepted in English only.

Number of Submissions

There is no limit to the number of abstract submissions, as long as the presenting author is present at the poster during the Poster and Exhibit Viewing Session in the afternoon of Saturday, October 12th. 


                                                                                                                                                                                                       Back to top


Platform Presentation Information

The platform presentations will be scheduled during one plenary and one concurrent session. Each presentation is scheduled for 15 minutes including questions from the audience. Presentation specifics will be communicated to the submitting author closer to the Symposium date. The first author must be the presenting author, and will receive a certificate of presentation. 


Poster Display Details

Number of Submissions

Posters will be on display on poster boards on Friday, October 11th and Saturday, October 12th. Poster display requirements will be communicated to the submitting author closer to the Symposium date.

Poster Viewing Session Attendance - Mandatory

Presenting authors must be present during the Poster and Exhibit Viewing Session in the afternoon of Saturday, October 12th. 


Poster and Platform Presentation Award

Poster Award

Poster presentations will be judged by the ISOPP and BOPA Research Committee and the best poster will be awarded with a certificate. Presenting authors have to be ISOPP or BOPA members. Encore presentations are not eligible for the Poster Award.



If you have any questions regarding the abstract submission system contact the Abstract Manager at abstract@isopp.org.

If you have any questions regarding scientific content, contact Jennifer Jupp, ISOPP Research Committee Chair by email at research@isopp.org.

Sign up for ISOPP’s Community Newsletter to receive updates about abstract submission. If you are an ISOPP member, you are already signed up.


                                                                                                                                                                                                          Back to top